Ameliorative potential of Butea monosperma on chronic constriction injury of sciatic nerve induced neuropathic pain in rats

Anais da Academia Brasileira de Ciencias

Volumn 84, Issue 4, 2012, Pages 1091-1104

  Thiagarajan, Venkata Rathina Kumar ^a,b   Shanmugam, Palanichamy ^c   Krishnan, Uma M ^a   Muthuraman, Arunachalam ^d   Singh, Nirmal ^d  

^a SASTRA UNIVERSITY   (India)

^b MADURAI MEDICAL COLLEGE   (India)

^c Sankaralingam Bhuvaneshwari College of Pharmacy   (India)

^d PUNJABI UNIVERSITY   (India)

Author keywords

Anti oxidant; Butea monosperma; Calcium; Chronic constriction injury; Reduced glutathione; Thiobarbituric acid reactive substance

Indexed keywords

PLANT EXTRACT;

ANIMAL; ARTICLE; BUTEA; CHEMISTRY; CHRONIC DISEASE; DISEASE MODEL; FEMALE; LIGATION; MALE; NEURALGIA; RAT; SCIATIC NEUROPATHY; WISTAR RAT;

ANIMALS; BUTEA; CHRONIC DISEASE; CONSTRICTION; DISEASE MODELS, ANIMAL; FEMALE; MALE; NEURALGIA; PLANT EXTRACTS; RATS; RATS, WISTAR; SCIATIC NEUROPATHY;

BUTEA MONOSPERMA; RATTUS;

EID: 84870928068     PISSN: 00013765     EISSN: 16782690     Source Type: Journal    
DOI: 10.1590/S0001-37652012005000063     Document Type: Article

References (61)

1. ADAMS M, GMÜNDER F and HAMBURGER M. 2007. Plants traditionally used in age related brain disorders-A survey of ethnobotanical literature. J Ethnopharmacol 113: 363-381.
2. AGARWAL AK, SINGH M, GUPTA N, SAXENA R, PURI A, VERMA AK, SAXENA RP, DUBEY CB and SAXENA KC. 1994. Management of giardiasis by an immuno-modulatory herbal drug Pippali rasayana. J Ethnopharmacol 44: 143-146.
3. AGARWAL AK, TRIPATHI DM, SAHAI R, GUPTA N, SAXENA RP, PURI A, SINGH M, MISRA RN, DUBEY CB and SAXENA KC. 1997. Management of giardiasis by a herbal drug 'Pippali Rasayana: a clinical study. J Ethnopharmacol 56: 233-236.
4. ALSTON RP and PECHON P. 2005. Dysaesthesia associated with sternotomy for heart surgery. Br J Anaesth 95: 153-158.
5. ANONYMOUS. 2006. The ayurvedic pharmacopoeia of India, Part I. Volume II and V. Government of India, Ministry of Health and Family Welfare New Delhi, p. 128-130.
6. BABBAR S, MARIER JF, MOUKSASSI MS, BELIVEAU M, VANHOVE GF, CHANDA S and BLEY K. 2009. Pharma cokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic pain. Ther Drug Monit 31: 502-510.
7. BANDYOPADHYAY U, DAS D and BANARJEE RK. 1999. Reactive oxygen species: Oxidative damage and pathogenesis. Curr Sci 77: 658-665.
8. BENDER G, FLORIAN Jr JA, BRAMWELL S, FIELD MJ, TAN KK, MARSHALL S, DEJONGH J, BIES RR and DANHOF M. 2010. Pharmacokinetic-pharmacodynamic analysis of the static allodynia response to pregabalin and sildenafil in a rat model of neuropathic pain. J Pharmacol Exp Ther 334: 599-608.
9. BENNETT GJ and XIE YK. 1988. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33: 87-107.
10. CAROL W and JANE K. 2006. Evidence-Based Treatment of Diabetic Peripheral Neuropathy. J Nurse Pract 2: 370-378.
11. CARRIEDO SG, SENSI SL, YIN HZ and WEISS JH. 2000. AMPA exposures induce mitochondrial Ca (2+) overload and ROS generation in spinal motor neurons in vitro. J Neurosci 20: 240-250.
12. CHAPLAN SR, BACH FW, POGREL JW, CHUNG JM and YAKSH TL. 1994. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53: 55-63.
13. CHOI Y, YOON YW, NA HS, KIM SH and CHUNG JM. 1994. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain 59: 369-376.
14. DAVIET JC, PREUX PM, SALLE JY, LEBRETON F, MUNOZ M, DUDOGNON P, PELISSIER J and PERRIGOT M. 2002. Clinical factors in the prognosis of complex regional pain syndrome type 1 after stroke: a prospective study. Am J Phys Med Rehabil 81: 34-39.
15. DWORKIN RH et al. 2010. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 85: S3-S14.
16. EDDY NB, TOUCHBERRY CF and LIEBERMAN JE. 1950. Synthetic analgesics: I. Methadone isomers and derivatives. J Pharmacol Exp Ther 98: 121-137.
17. ELLIS RJ, TOPEROFF W, VAIDA F, VAN DEN BRANDE G, GONZALES J, GOUAUX B, BENTLEY H and ATKINSON JH. 2009. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsycho pharmacology 34: 672-680.
18. ELLMAN GL. 1959. Tissue sulfhydryl groups. Arch Biochem Biophys 82: 70-77.
19. GAO X, KIM HK, CHUNG JM and CHUNG K. 2007. Reactive oxygen species (ROS) are involved in enhancement of NMDA-receptor phosphorylation in animal models of pain. Pain 131: 262-271.
20. GLASS JD, CULVER DG, LEVEY AI and NASH NR. 2002. Very early activation of m-calpain in peripheral nerve during Wallerian degeneration. J Neurol Sci 196: 9-20.
21. GURAV SS, GULKARI VD, DURAGKAR NJ and PATIL AT. 2008. Antimicrobial activity of Butea monosperma Lam. Gum. IJPT 7: 21-24.
22. HONDA K, CASADESUS G, PETERSEN RB, PERRY G and SMITH MA. 2004. Oxidative stress and redox-active iron in Alzheimer's disease. Ann N Y Acad Sci 1012: 179-182.
23. KALITA J, VAJPAYEE A and MISRA UK. 2006. Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: a randomized controlled trial. QJM 99: 89-95.
24. KASTURE VS, CHOPDE CT and DESMUKH VK. 2000. Anticonvulsive activity of Albizzia lebbeck, Hibiscus rosasinensis, and Butea monosperma in experimental animals. J Ethnopharmacol 71: 65-75.
25. KIM YS, PARK HJ, KIM TK, MOON DE and LEE HJ. 2009. The effects of Ginkgo biloba extract EGb 761 on mechanical and cold allodynia in a rat model of neuropathic pain. Anesth Analg 108: 1958-1963.
26. KOLTZENBURG M and SCADDING J. 2001. Neuropathic pain. Curr Opin Neurol 14: 641-647.
27. KOSTOFF RN, BRIGGS MB and LYONS TJ. 2008. Literaturerelated discovery (LRD): Potential treatments for multiple sclerosis. Technol Forecast Soc Change 75: 239-255.
28. KRAMER HH, HE L, LU B, BIRKLEIN F and SOMMER C. 2009. Increased pain and neurogenic inflammation in mice deficient of neutral endopeptidase. Neurobiol Dis 35: 177-183.
29. KRITHIKAR KR and BASU BD. 1989. Butea monosperma. In: Blatter E, Caius JF and Mahaskar KS (Eds), In indian medicinal plants. Shiva offset press, Dehradun, p. 785-788.
30. KUMAR N, LAFERRIERE A, YU JS, LEAVITT A and CODERRE TJ. 2010. Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate. J Neurochem 113: 552-561.
31. LAVHALE MS and MISHRA SH. 2007. Evaluation of free radical scavengivg activity of Butea monosperma Lam. Indian J Exp Biol 45: 376-384.
32. LEE J and NANDI P. 2010. Improving the management of neuropathic pain. Practitioner 254: 27-30.
33. LOWRY OH, ROSENBROUGH NJ, FARR AL and RANDALL RJ. 1951. Protein measurement with folin phenol reagent. J Biol Chem 193: 265-275.
34. MANYAM BV. 1999. Dementia in ayurveda. J Altern Complement Med 5: 81-88.
35. MENGI SA and DESHPANDE SG. 1995. Evaluation of ocular anti-inflammatory activity of Butea frondosa. Indian J Pharmacol 27: 116-119.
36. MUTHURAMAN A, DIWAN V, JAGGI AS, SINGH N and SINGH D. 2008a. Ameliorative effects of Ocimum sanctum in sciatic nerve transection Induced neuropathy in rats. J Ethnopharmacol 120: 56-62.
37. MUTHURAMAN A, JAGGI AS, SINGH N and SINGH D. 2008b. Ameliorative effects of amiloride and pralidoxime in chronic constriction injury and vincristine induced painful neuropathy in rats. Eur J Pharmacol 587: 104-111.
38. MUTHURAMAN A and SINGH N. 2011. Attenuating effect of Acorus calamus extract in chronic constriction injury induced neuropathic pain in rats: an evidence of antioxidative, anti-inflammatory, neuroprotective and calcium inhibitory effects. BMC Complement Altern Med 11: 24-37.
39. MUTHURAMAN A and SOOD S. 2010. Pharmacological evaluation of tacrolimus (FK-506) on ischemia reperfusion induced vasculatic neuropathic pain in rats. J Brachial Plex Peripher Nerve Inj 5: 13-23.
40. NAGLER RM. 2010. CRPS: Central aspects related to locus of pain, pathophysiology, and mood. Neurology 75: 109-110.
41. NECKER R and HELLON RF. 1978. Noxious thermal input from the rat tail: modulation by descending inhibitory influences. Pain 4: 231-242.
42. OKHAWA H, OHISHI N and YAGI K. 1979. Assay for lipid peroxidation in animal tissue by thiobarbituric acid reaction. Analyt Biochem 95: 351-358.
43. OTTO M, BAK S, BACH FW, JENSEN TS and SINDRUP SH. 2003. Pain phenomena and possible mechanisms in patients with painful polyneuropathy. Pain 101: 187-192.
44. PARK HJ, JOO HS, CHANG HW, LEE JY, HONG SH, LEE Y and MOON DE. 2010. Attenuation of neuropathy-induced allodynia following intraplantar injection of pregabalin. Can J Anaesth 57: 664-671.
45. PRAMOD K. 2006. Chronic pain syndromes (Non terminal illness). Indian J Anaesth 50: 391-396.
46. RANDALL LO and SELITTO J. 1957. A method for measurement of analgesic activity of inflammed tissue. Arch Int Pharmacodyn Ther 111: 209-219.
47. SAI KRISHNA N, RANGANAYAKULU D, SUJATHA D, PUSHPA KUMARI B, VENKATESWARALU M and GOPIC H and CHIN TA. 2010. Anti-oxidant activity of the Butea monosperma leaves alone and in combination with atrovastatin. Drug Invention Today 2: 149-151.
48. SEHRAWAT A and SULTANA S. 2006. Chemoprevention by Butea monosperma of hepatic carcinogenesis and oxidative damage in male wistar rats. Asian Pac J Cancer Prev 7: 140-148.
49. SEVERINGHAUS JW and FERREBEE JW. 1950. Calcium determination by flame photometry; methods for serum, urine, and other fluids. J Biol Chem 187: 621-630.
50. SHAHAVI VM and DESAI SK. 2008. Anti-inflammatory activity of Butea monosperma flowers. Fitoterapia 79: 82-85.
51. SHARMA N and GARG V. 2009. Antidiabetic and antioxidant potential of ethanolic extract of Butea monosperma leaves in alloxan-induced diabetic mice. Indian J Biochem Biophys 46: 99-105.
52. SHARRNA N and GARG V. 2009. Antihyperglycemic and antioxidative potential of hydroalcoholic extract of Butea monosperma. Lam. flowers in alloxan-induced diabetic mice. Indian J Exp Biol 47: 571-576.
53. SHUKLA YN, MISHRA M and SUSHIL K. 2002. Euphane triterpenoid ester and a pterocarpan fron Butea monosperma leaves. Indian J Chem 41B: 881-883.
54. SOMAN I, MENGI SA and KASTURE SB. 2004. Effect of leaves of Butea frondosa on Stress, anxiety, and cognition in rats. Pharmacol Biochem Behav 79: 11-16.
55. SOMMER C and SCHAFERS M. 1998. Painful mononeuropathy in C57BL/Wld mice with delayed wallerian degeneration: differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity. Brain Res 784: 154-162.
56. STANCIU M et al. 2000. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J Biol Chem 275: 12200-12206.
57. SUDOH Y, DESAI SP, HADERER AE, SUDOH S, GERNER P, ANTHONY DC, DE GIROLAMI U and WANG GK. 2004. Neurologic and histopathologic evaluation after high volume intrathecal amitriptyline. Reg Anesth Pain Med 29: 434-440.
58. Suzgec-Selcuk S and BIRTEKSOZ AS. 2011. Flavonoids of Helichrysum chasmolycicum and its antioxidant and antimicrobial activities. S Afr J Bot 77: 170-174.
59. VARIER SPV. 1995. Indian Medicinal Plants. Long man publisher, Madras.
60. WOOLF CJ and MANNION RJ. 1999. Neuropathic pain: Aetiology, symptoms, mechanisms and management. Lancet 353: 1959-1964.
61. 2+ triggered protease activity and cytoskeletal disassembly. J Neurosci 11: 3257-3267.